Buchumschlag

Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study

AbstractBackground. In the randomized controlled RESTORE-IMI 1 clinical trial (NCT02452047), imipenem/cilastatin (IMI) with relebactam (IMI/REL) was as effecti

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Brown, Michelle L. (VerfasserIn) , Motsch, Johann (VerfasserIn) , Kaye, Keith S. (VerfasserIn) , File, Thomas M. (VerfasserIn) , Boucher, Helen W. (VerfasserIn) , Vendetti, Neika (VerfasserIn) , Aggrey, Angela (VerfasserIn) , Joeng, Hee-Koung (VerfasserIn) , Tipping, Robert W. (VerfasserIn) , Du, Jiejun (VerfasserIn) , DePestel, Daryl D. (VerfasserIn) , Butterton, Joan R. (VerfasserIn) , Paschke, Amanda (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2020]
In: Open Forum Infectious Diseases
Year: 2020, Jahrgang: 7, Heft: 3
ISSN:2328-8957
DOI:10.1093/ofid/ofaa054
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/ofid/ofaa054
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/ofid/article/7/3/ofaa054/5740221
Volltext
Verfasserangaben:Michelle L. Brown, Johann Motsch, Keith S. Kaye, Thomas M. File, Helen W. Boucher, Neika Vendetti, Angela Aggrey, Hee-Koung Joeng, Robert W. Tipping, Jiejun Du, Daryl D. DePestel, Joan R. Butterton, and Amanda Paschke

MARC

LEADER 00000caa a2200000 c 4500
001 1695282663
003 DE-627
005 20230426133537.0
007 cr uuu---uuuuu
008 200421s2020 xx |||||o 00| ||eng c
024 7 |a 10.1093/ofid/ofaa054  |2 doi 
035 |a (DE-627)1695282663 
035 |a (DE-599)KXP1695282663 
035 |a (OCoLC)1341315891 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Brown, Michelle L.  |e VerfasserIn  |4 aut 
245 1 0 |a Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study  |c Michelle L. Brown, Johann Motsch, Keith S. Kaye, Thomas M. File, Helen W. Boucher, Neika Vendetti, Angela Aggrey, Hee-Koung Joeng, Robert W. Tipping, Jiejun Du, Daryl D. DePestel, Joan R. Butterton, and Amanda Paschke 
264 1 |c [2020] 
300 |b Diagramme 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.04.2020 
520 |a AbstractBackground. In the randomized controlled RESTORE-IMI 1 clinical trial (NCT02452047), imipenem/cilastatin (IMI) with relebactam (IMI/REL) was as effecti 
700 1 |a Motsch, Johann  |d 1952-  |e VerfasserIn  |0 (DE-588)1059446626  |0 (DE-627)798468319  |0 (DE-576)415532876  |4 aut 
700 1 |a Kaye, Keith S.  |e VerfasserIn  |4 aut 
700 1 |a File, Thomas M.  |e VerfasserIn  |4 aut 
700 1 |a Boucher, Helen W.  |e VerfasserIn  |4 aut 
700 1 |a Vendetti, Neika  |e VerfasserIn  |4 aut 
700 1 |a Aggrey, Angela  |e VerfasserIn  |4 aut 
700 1 |a Joeng, Hee-Koung  |e VerfasserIn  |4 aut 
700 1 |a Tipping, Robert W.  |e VerfasserIn  |4 aut 
700 1 |a Du, Jiejun  |e VerfasserIn  |4 aut 
700 1 |a DePestel, Daryl D.  |e VerfasserIn  |4 aut 
700 1 |a Butterton, Joan R.  |e VerfasserIn  |4 aut 
700 1 |a Paschke, Amanda  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Open Forum Infectious Diseases  |d Oxford : Oxford University Press, 2014  |g 7(2020,3) Artikel-Nummer ofaa054, Seite 1-7  |h Online-Ressource  |w (DE-627)779394089  |w (DE-600)2757767-3  |w (DE-576)401709566  |x 2328-8957  |7 nnas  |a Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study 
773 1 8 |g volume:7  |g year:2020  |g number:3  |g extent:7  |a Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study 
856 4 0 |u https://doi.org/10.1093/ofid/ofaa054  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/ofid/article/7/3/ofaa054/5740221  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200421 
993 |a Article 
994 |a 2020 
998 |g 1059446626  |a Motsch, Johann  |m 1059446626:Motsch, Johann  |d 910000  |d 910300  |e 910000PM1059446626  |e 910300PM1059446626  |k 0/910000/  |k 1/910000/910300/  |p 2 
999 |a KXP-PPN1695282663  |e 362775400X 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 21.04.2020"],"name":{"displayForm":["Michelle L. Brown, Johann Motsch, Keith S. Kaye, Thomas M. File, Helen W. Boucher, Neika Vendetti, Angela Aggrey, Hee-Koung Joeng, Robert W. Tipping, Jiejun Du, Daryl D. DePestel, Joan R. Butterton, and Amanda Paschke"]},"id":{"eki":["1695282663"],"doi":["10.1093/ofid/ofaa054"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1695282663","relHost":[{"id":{"eki":["779394089"],"issn":["2328-8957"],"zdb":["2757767-3"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"7","issue":"3","text":"7(2020,3) Artikel-Nummer ofaa054, Seite 1-7","year":"2020","volume":"7"},"note":["Gesehen am 07.08.2020"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 studyOpen Forum Infectious Diseases","title":[{"title":"Open Forum Infectious Diseases","title_sort":"Open Forum Infectious Diseases"}],"pubHistory":["2014 -"],"recId":"779394089","origin":[{"publisherPlace":"Oxford","publisher":"Oxford University Press","dateIssuedDisp":"2014-","dateIssuedKey":"2014"}],"language":["eng"]}],"origin":[{"dateIssuedDisp":"[2020]","dateIssuedKey":"2020"}],"language":["eng"],"title":[{"title_sort":"Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study","title":"Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study"}],"person":[{"display":"Brown, Michelle L.","role":"aut","given":"Michelle L.","family":"Brown","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","given":"Johann","family":"Motsch","role":"aut","display":"Motsch, Johann"},{"family":"Kaye","given":"Keith S.","roleDisplay":"VerfasserIn","display":"Kaye, Keith S.","role":"aut"},{"roleDisplay":"VerfasserIn","family":"File","given":"Thomas M.","role":"aut","display":"File, Thomas M."},{"family":"Boucher","given":"Helen W.","roleDisplay":"VerfasserIn","display":"Boucher, Helen W.","role":"aut"},{"family":"Vendetti","given":"Neika","roleDisplay":"VerfasserIn","display":"Vendetti, Neika","role":"aut"},{"given":"Angela","family":"Aggrey","roleDisplay":"VerfasserIn","display":"Aggrey, Angela","role":"aut"},{"display":"Joeng, Hee-Koung","role":"aut","family":"Joeng","given":"Hee-Koung","roleDisplay":"VerfasserIn"},{"display":"Tipping, Robert W.","role":"aut","given":"Robert W.","family":"Tipping","roleDisplay":"VerfasserIn"},{"display":"Du, Jiejun","role":"aut","family":"Du","given":"Jiejun","roleDisplay":"VerfasserIn"},{"role":"aut","display":"DePestel, Daryl D.","roleDisplay":"VerfasserIn","family":"DePestel","given":"Daryl D."},{"family":"Butterton","given":"Joan R.","roleDisplay":"VerfasserIn","display":"Butterton, Joan R.","role":"aut"},{"role":"aut","display":"Paschke, Amanda","roleDisplay":"VerfasserIn","family":"Paschke","given":"Amanda"}],"physDesc":[{"extent":"7 S.","noteIll":"Diagramme"}]} 
SRT |a BROWNMICHEEVALUATION2020 

Ähnliche Einträge